Myopericarditis in a patient with COVID 19

Authors

  • Máximo Silva Gutiérrez Hospital Naval. La Habana, Cuba.
  • Eric A. Tamayo Suárez Hospital Militar Central. Dr. Luis Diaz Soto

Abstract

In December 2019, several cases of severe pneumonia, caused by an unknown agent were reported in China. It was named SARS-CoV-2 and it causes COVID-19. This disease, considered a pandemic because of its high contagiousness and worldwide spread, presents cardiovascular complications in some patients. Myopericarditis is one of them. The clinical condition, the use of the electrocardiogram, echocardiogram, and markers of myocardial damage are essential for the diagnosis of this disease in a patient with COVID 19. Working in a multidisciplinary group is essential to improve medical care in these patients.

Downloads

Download data is not yet available.

References

1. Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Med Lab [Internet]. 2020 [citado 19 Mar 2022];24(3):183-205. Disponible en: https://doi.org/10.36384/01232576.268

2. Ministerio de Salud Pública (MINSAP). COVID-9: Parte de cierre del día 17 de marzo a las 12 de la noche. La Habana: Portal Web Oficial Ministerio de Salud Pública [Internet]; 2022 [citado 19 Mar 2022]. Disponible en: https://salud.msp.gob.cu/parte-de-cierre-del-dia-17-de-marzo-a-las-12-de-la-noche-2/

3. Forero-Saldarriaga S, Puerta-Rojas JD, Estupiñán-Paredes RN, Coy-Pedraza LC, Moreno-Ruiz NL, Castellanos-Parada J. Infección por SARS-CoV-2 y miocarditis. Med Lab. [Internet]. 2022 [citado 20 Mar 2022];26(1):35-46. Disponible en: https://doi.org/10.36384/01232576.558

4. Moreno-Martínez FL, Moreno-López FL, Oroz R. Repercusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19). CorSalud [Internet]. 2020 [citado 20 Mar 2022];12(1):3-17. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/588/1113

5. Caballeros Lam M, de la Fuente Villena A, Hernández Hernández A, García de Yébenes M, Bastarrika Alemañ G. Caracterización de la miocarditis por COVID-19 mediante resonancia magnética cardiaca. Rev Esp Cardiol. 2020;73(10):863-4. DOI: https://doi.org/10.1016/j.recesp.2020.06.032

6. Casabé H, Klin P, Oberti P, Trivi M, Vázquez M. Consenso Enfermedades del Pericardio. Rev Argent Cardiol. 2017;85(Supl 7):1-54.

7. Tung-Chen Y, Blanco-Alonso S, Antón-Huguet B, Figueras-López C, Ugueto-Rodrigo C. Dolor torácico persistente tras resolución de la enfermedad por coronavirus 2019 (COVID-19). Semergen. 2020;46(Supl 1):88-90. DOI: https://doi.org/10.1016/j.semerg.2020.06.006

8. Pérez Cabrera LA, Planas Sliuntieva NL, Aroche Aportela R. Miocarditis post COVID-19: A propósito de un caso tratado con Jusvinza. Invest Medicoquir [Internet];13(3). 2021 [citado 23 Mar 2022]. Disponible en: http://www.revcimeq.sld.cu/index.php/imq/article/view/716

9. Pérez-Acosta G, Santana-Cabrera L, Blanco-López J, Martín-González JC. Miopericarditis por COVID-19: A propósito de un caso. Rev Clin Esp (Barc). 2021;221(5):312-3. DOI: https://doi.org/10.1016/j.rce.2020.11.008

10. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. DOI: https://doi.org/10.1007/s00134-020-05991-x

11. Tufo-Pereyra A, Scatularo CE, Cardone F, Grancelli H. Pericarditis por SARS-CoV-2: Informe de caso. Arch Cardiol Mex. 2021;91(Supl 2):140-2. DOI: https://doi.org/10.24875/acm.21000033

Downloads

Published

2022-11-02

How to Cite

1.
Gutiérrez MS, Tamayo Suárez EA. Myopericarditis in a patient with COVID 19. CorSalud [Internet]. 2022 Nov. 2 [cited 2025 Jul. 30];14(3):297-301. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/907

Issue

Vol. 14 No. 3 (2022)

Section

CASE REPORTS

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.